Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-23

Clinical Trial Update: Impact of Accu-Chek 360 in Veterans With Type 2 Diabetes [NA]

View source ↗

Summary

This update summarizes the results of a completed clinical trial evaluating the Accu-Chek 360 glucose monitoring system in veterans with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Accu-Chek 360

Snippet

Sponsor: Biomedical Research Institute of New Mexico | Conditions: Type 2 Diabetes | NA | Status: COMPLETED